Mirum Pharmaceuticals Inc Financial Flexibility Index
Mirum Pharmaceuticals Inc financial flexibility index. Mirum Pharmaceuticals Inc (MIRM) has a Financial Flexibility Index of -0.35x as of March 2026. Free cash flow of $-228.10 Million (operating CF $-228.76 Million minus capex $664.00K) represents 0% of total liabilities ($648.42 Million). Explore Mirum Pharmaceuticals Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Mirum Pharmaceuticals Inc (2018–2025)
Financial flexibility index of Mirum Pharmaceuticals Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Mirum Pharmaceuticals Inc across 8 annual periods. Check MIRM capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Mirum Pharmaceuticals Inc Financial Flexibility Index by Year (2018–2025)
Mirum Pharmaceuticals Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Mirum Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Mirum Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | $56.78 Million | $55.83 Million | $528.12 Million | ▲ +322.8% |
| 2024 | 0.03x | $11.32 Million | $10.32 Million | $445.11 Million | ▲ +119.9% |
| 2023 | -0.13x | $-50.84 Million | $-70.94 Million | $397.95 Million | ▲ +77.5% |
| 2022 | -0.57x | $-119.86 Million | $-120.14 Million | $210.87 Million | ▲ +12.8% |
| 2021 | -0.65x | $-113.73 Million | $-132.76 Million | $174.44 Million | ▲ +49.5% |
| 2020 | -1.29x | $-88.85 Million | $-89.08 Million | $68.77 Million | ▲ +45.9% |
| 2019 | -2.39x | $-39.08 Million | $-39.36 Million | $16.36 Million | ▼ -2187.7% |
| 2018 | 0.11x | $7.13 Million | $-373.00K | $62.30 Million | — |